Prithviraj Bose

62PUBLICATIONS
180CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Feb 13, 2026
Clinical, genetic, and familial features of POT1 tumor predisposition syndrome.

Courtney D DiNardo, Jennifer Croden, Hiam M Abdel-Salam

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Nov 24, 2025
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.

Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas

|Sep 19, 2025
Ruxolitinib Meets a Forgotten Malady.

Jennifer Makhoul, Chia-Yu Chiu, Cindy Berthelot

Pageof 11

Frequent Collaborators

18 joint publications

Tapan M Kadia

17 joint publications

Courtney DiNardo

17 joint publications

Hagop M Kantarjian

16 joint publications

Naveen Pemmaraju